Clinical trials recruiting for HR Positive/HER-2 Negative Breast Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
20
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CGT6297 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Florida | 2 |
| Missouri | 2 |
| New Jersey | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Alabama | 1 |
| Arizona | 1 |
| Colorado | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Massachusetts | 1 |
Top cities
Nashville, Tennessee 2Ann Arbor, Michigan 1Austin, Texas 1Birmingham, Alabama 1Boston, Massachusetts 1Carbondale, Illinois 1Cincinnati, Ohio 1Denver, Colorado 1East Brunswick, New Jersey 1Fairfax, Virginia 1
Self-screener
Recruiting trials
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Related conditions
Trials recruiting for HR Positive/HER-2 Negative Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239TNBC - Triple-Negative Breast Cancer 35HER2-low Breast Cancer 7HER2 + Breast Cancer 15Endometrial cancer 68Early Stage Breast Cancer 27
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HR Positive/HER-2 Negative Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.